Lipocine (LPCN) Stock Price, Quote, News & History | Benzinga

SPY779.62+0.07%QQQ760.13+0.06%BTC/USD85,606.34−0.17%DIA514.58+0.00%GLD381.78−0.13%TLT77.22−0.08%

Lipocine Inc (LPCN) Stock Price, Quote, News & History

LPCNNASDAQ

Trade with Public

Trade with Public

$2.10

0.031.45%

Last update: Oct 6, 9:29 AM

$2.05

-0.02-0.97%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$2.07

Close

$2.10

Volume / Avg.

12.72K / 36.69K

Day Range

$2.07 - $2.10

52 Wk Range

1.81 - 12.37

Market Cap

$16.90M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

45

Short Interest

1.23%

Days to Cover

4.58

Recent Lipocine Inc News

What's Going On With Carvana Stock Monday?

BofA downgrades Carvana (CVNA) to Neutral, cutting the price target to $360. Explore the latest analyst insights and technical support levels.

Lekha Gupta

What's Going On With Lipocine Stock On Monday?

Lipocine stock rebounds after a steep drop as LPCN 1154 misses the Phase 3 endpoint, with encouraging subgroup data.

Vandana Singh

This Carvana Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Wall Street analysts changed their outlook on top names. Check out the ratings page for complete changes. Check out what analysts think about CVNA.

Avi Kapoor

Crude Oil Rises Sharply; Acuity Shares Fall After Q2 Results

US stocks fall, Dow drops over 50 points, real estate shares rise, Acuity Inc. shares decline, Sky Quarry Inc. and Cocrystal Pharma Inc. shares increase.

Avi Kapoor

Lipocine Stock Plunges After LPCN 1154 Misses Phase 3 Primary Endpoint

Lipocine Inc. shares are trading lower Thursday after reporting topline safety and efficacy results for LPCN 1154 in postpartum depression.

Dylan Berman

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-11.19M

Investing Cash Flow (TTM)

-6.15M

Financing Cash Flow (TTM)

16.27M

Free Cash Flow (TTM)

-11.19M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-1.06M

Analyst Trends and Forecast

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$6.04M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

9.04

PB Ratio (TTM)

0.79

Earnings Yield % (TTM)

-88.52%

Earnings Yield % (FWD)

-64.11%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.64

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$4.98M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-